The professional society circus.

Suppr

超能文献

作者信息

Kassirer Jerome P

机构信息

Tufts University School of Medicine, 136 Harrison Avenue, Boston, MA 02111, USA.

出版信息

J Public Health Policy. 2005 Dec;26(4):400-3. doi: 10.1057/palgrave.jphp.3200048.

DOI:10.1057/palgrave.jphp.3200048

PMID:16392739

Abstract

摘要

相似文献

The professional society circus.

J Public Health Policy. 2005 Dec;26(4):400-3. doi: 10.1057/palgrave.jphp.3200048.

Violations of exhibiting and FDA rules at an American Psychiatric Association annual meeting.

J Public Health Policy. 2005 Dec;26(4):389-99. doi: 10.1057/palgrave.jphp.3200049.

Pros and cons of off-label promotion investigations and prosecutions.

Food Drug Law J. 2006;61(3):577-83.

Shifting terrain in the regulation of off-label promotion of pharmaceuticals.

N Engl J Med. 2009 Apr 9;360(15):1557-66. doi: 10.1056/NEJMhle0807695.

Off-label or off-limits?

Nat Biotechnol. 2008 Aug;26(8):867-75. doi: 10.1038/nbt0808-867.

Conflicts of interest between physicians and the pharmaceutical industry and special interest groups.

Child Adolesc Psychiatr Clin N Am. 2008 Jan;17(1):113-25, ix-x. doi: 10.1016/j.chc.2007.07.007.

Pharmaceutical promotion and First Amendment rights.

N Engl J Med. 2008 Jul 31;359(5):536; author reply 536-7. doi: 10.1056/NEJMc081122.

Treatment traps to avoid. Insured? You're money in the bank to the health-care system.

Consum Rep. 2007 Nov;72(11):12-7.

Major issues in marketing regulation.

Food Drug Law J. 1997;52(3):297-302.

Pharmaceutical promotion to physicians and First Amendment rights.

N Engl J Med. 2008 Apr 17;358(16):1727-32. doi: 10.1056/NEJMsb0708920.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

The professional society circus.

J Public Health Policy. 2005 Dec;26(4):400-3. doi: 10.1057/palgrave.jphp.3200048.

Violations of exhibiting and FDA rules at an American Psychiatric Association annual meeting.

J Public Health Policy. 2005 Dec;26(4):389-99. doi: 10.1057/palgrave.jphp.3200049.

Pros and cons of off-label promotion investigations and prosecutions.

Food Drug Law J. 2006;61(3):577-83.

Shifting terrain in the regulation of off-label promotion of pharmaceuticals.

N Engl J Med. 2009 Apr 9;360(15):1557-66. doi: 10.1056/NEJMhle0807695.

Off-label or off-limits?

Nat Biotechnol. 2008 Aug;26(8):867-75. doi: 10.1038/nbt0808-867.

Conflicts of interest between physicians and the pharmaceutical industry and special interest groups.

Child Adolesc Psychiatr Clin N Am. 2008 Jan;17(1):113-25, ix-x. doi: 10.1016/j.chc.2007.07.007.

Pharmaceutical promotion and First Amendment rights.

N Engl J Med. 2008 Jul 31;359(5):536; author reply 536-7. doi: 10.1056/NEJMc081122.

Treatment traps to avoid. Insured? You're money in the bank to the health-care system.

Consum Rep. 2007 Nov;72(11):12-7.

Major issues in marketing regulation.

Food Drug Law J. 1997;52(3):297-302.

Pharmaceutical promotion to physicians and First Amendment rights.

N Engl J Med. 2008 Apr 17;358(16):1727-32. doi: 10.1056/NEJMsb0708920.